Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.
about
Investigational drugs to treat methicillin-resistant Staphylococcus aureusTreatment of Gram-positive infections in critically ill patientsGlucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus PersistersTedizolid Phosphate: a Next-Generation Oxazolidinone.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis.Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibioticsEvolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genomeDaptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerIn Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model.Impact of daptomycin resistance on Staphylococcus aureus virulence.Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams.Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient.Daptomycin.Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.The Combination of Daptomycin plus Fosfomycin has Synergistic, Potent and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) in a Rabbit Model of Experimental Endocarditis (EE).
P2860
Q26780246-F256835F-04EA-44CF-BB9E-9D02D8A7858AQ27015976-7687D60F-0CF4-4FE1-8693-EE479E0CBD9DQ28550612-3BF586F8-DD86-46D5-BD82-2E13670B3BCBQ33420646-611259F6-374F-41A9-BB91-97504695F108Q34478074-653B912E-6F12-4296-873F-D30FEDF2CF07Q34801960-B1A36855-59FF-4033-B7ED-793DC9B89EA4Q35385568-AC234FC7-4FF2-4F34-9043-877F62F460F9Q35607708-668BB1C0-B961-4257-8174-F440D4602B6EQ35926840-57767556-5F4D-441E-BDE5-2D6D3358D291Q36076047-18498D5C-75CF-4776-BFDC-816CD3A52068Q36147127-D69611CD-EF55-4178-852B-EBE8060EF5FDQ36439147-B39A059C-57E0-46A9-AA2A-9633C0BA512BQ37203885-E4715BC6-0F1C-44A2-A906-A290A7F27BD7Q37613052-DC6CE9A2-7DD4-4D78-AD15-5EA5F7E581E7Q38895642-698E2031-0841-4E30-BE63-6878EDA31FEBQ40536868-EFC7E511-C221-4556-86D2-FFB958770BA0Q40845477-A1951231-62B8-4608-95C6-C38B2AE97FA1Q41096202-15A21795-651D-4E31-B10A-987973540DF2Q47616115-C947C6EE-F57F-4BA2-9248-68CC24F917C5Q47634145-5671E113-86D1-43BC-9EEF-4F458A86E684Q53699196-984176C7-BC9A-491E-A3F2-907CC631CAFE
P2860
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Emergence of resistance to dap ...... aemia treated with daptomycin.
@en
Emergence of resistance to dap ...... aemia treated with daptomycin.
@nl
type
label
Emergence of resistance to dap ...... aemia treated with daptomycin.
@en
Emergence of resistance to dap ...... aemia treated with daptomycin.
@nl
prefLabel
Emergence of resistance to dap ...... aemia treated with daptomycin.
@en
Emergence of resistance to dap ...... aemia treated with daptomycin.
@nl
P2093
P2860
P50
P356
P1476
Emergence of resistance to dap ...... aemia treated with daptomycin.
@en
P2093
A Granados
E Ruiz de Gopegui
F López-Medrano
G García-Pardo
J R Blanco
M A Domínguez
P2860
P304
P356
10.1093/JAC/DKT396
P407
P577
2013-10-09T00:00:00Z